risankizumab
SpainDrugs containing this active substance
-
It is used to treat moderate to severe plaque psoriasis in adults and psoriatic arthritis in adults.
Form: solution for injection in pre-filled pen
Active substance Dosage risankizumab 150 mg Manufacturer: Abbvie Deutschland Gmbh & Co. Kg
-
It is used to treat moderate to severe plaque psoriasis in adults and psoriatic arthritis in adults.
Form: solution for injection in a pre-filled syringe
Active substance Dosage risankizumab 150 mg Manufacturer: Abbvie Deutschland Gmbh & Co. Kg
-
It is used to treat adult patients with moderate to severe Crohn's disease or moderate to severe ulcerative colitis.
Form: solution for injection in cartridge
Active substance Dosage risankizumab 180 mg Manufacturer: Abbvie Deutschland Gmbh & Co. Kg
-
It is used to treat adult patients with moderate to severe Crohn's disease or moderate to severe ulcerative colitis.
Form: solution for injection in cartridge
Active substance Dosage risankizumab 360 mg Manufacturer: Abbvie Deutschland Gmbh & Co. Kg
-
It is used to treat adults with moderate to severe Crohn's disease or moderate to severe ulcerative colitis, helping to reduce inflammation and symptoms.
Form: solution for infusion, concentrate
Active substance Dosage risankizumab 600 mg Manufacturer: Abbvie Deutschland Gmbh & Co. Kg